glp 1 compound news 🚨 BREAKING GLP-1 #tirzepatide #semaglutide FDA says shortage of GLP-1

The National Family Health Survey (NFHS-4, 2015-16) reported that 20.7% of women and 18.6% of men in the 15-49 age group were overweight or obese, underscoring the urgent need for effective weight-loss solutions

One trial showed participants taking 7.2mg weekly losing on average 18.7%, with many reaching 20-25% weight loss thresholds

It says for existing cash paying customers, what about new cash patients

Temporarily reducing the GLP-1 medication dose or extending the titration schedule may allow better tolerance while maintaining therapeutic benefits

10.1016/j.apsb.2024.03.011 31 HernndezC.BogdanovP.CorralizaL.Garca-RamrezM.Sol-AdellC.ArranzJ